Thermo Fisher Scientific further strengthens its global response to COVID-19 to Support development and production of therapeutics and vaccines. This brings unmatched scalability, flexibility and expertise to enable customers to
Oncomine Precision Assay receives breakthrough device designation by the U.S FDA. Next-generation sequencing solutions of ThermoFisher Scientific helps to identify IDH1 and IDH2 mutations in low-grade glioma patients. Mumbai :
